Table 2: Treatment regimens according to the Mayo endoscopic subscore.

GroupABCD
Endoscopic subscore0123

No. of patients (%)9 (24%)15 (40%)10 (26%)4 (10%)
History of treatment in hospital
 Yes4 (44%)5 (33%)3 (30%)1 (25%)
 No5 (56%)10 (77%)7 (70%)3 (75%)
Remission induction therapy before colonoscopy
 Present9 (100%)15 (100%)10 (100%)4 (100%)
 5-Aminosalicylic acid9 (100%)15 (100%)10 (100%)3 (75%)
 Corticosteroid3 (33%)4 (27%)2 (20%)1 (25%)
 Local therapy5 (56%)7 (47%)6 (60%)3 (75%)
Duration of remission maintenance before
colonoscopy (months)
36.1 ± 32.428.7 ± 26.9 21.2 ± 22.424.3 ± 9.8
Drug therapy at colonoscopy
 Present8 (89%)14 (93%)10 (100%)4 (100%)
 5-Aminosalicylic acid8 (89%)13 (87%)10 (100%)3 (75%)
 Immunomodulators1 (11%)
 Local therapy1 (11%)2 (14%)3 (30%)1 (25%)
 None1 (11%)1 (7%)
Treatment after colonoscopy
 Present8 (89%)11 (73%)10 (100%)4 (100%)
 5-Aminosalicylic acid8 (89%)10 (77%)10 (100%)3 (75%)
 Immunomodulators
 Local therapy1 (7%)2 (20%)1 (25%)
 None1 (11%)4 (27%)